Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

The downside of declassifying cannabis as a schedule 1 drug

1 minute reading time (73 words)
cannabis

Moving cannabis drugs away from Schedule 1 to Schedule 2 or lower would positively impact the national cannabis industry. But there is a downside, too.

Cannabis drugs are federally illegal and are classified as Schedule 1 drugs in the United States. For a country where 35 out of 50 states have decriminalized or legalized the use of cannabis for medical reasons, this federal policy seems absurd.

(Originally posted by Cannabis News)

Copyright

© 420 Intel


Related Posts


MjInvest.com